Meet your next partner at Nordic Life Science Days
We welcome everyone working in life sciences – biotechnology, pharmaceuticals, medical devices, diagnostics and e-health – to the largest partnering conference in the Nordic region. During the meeting, in addition to private meetings with business partners through the internationally recognized partnering platform, there will be an extensive stage program. Of course, as a member you have a discount!
“At the SwedenBIO Executive Dinner I met Peter Gaskin of Charles River Labs who led our expansion into Switzerland”
Anna Fahlgren, CEO of Bioreperia, which develops zebrafish models in Linköping.
SwedenBIO driving the creation of a new hub for Nordic life science to invest internationally.
Together with regional and Nordic cooperation organizations, we want to create a hub with the task of advancing the position of Nordic life science in an international perspective. The goal is to increase the number of collaborations, both commercial and academic, while supporting the development of SwedenBIO’s member companies on the world market.
Business & Finance
How to create sustainable trading on the stock exchange
The life science sector is one of the strongest for listed small companies in Sweden. At the same time, the competition in the sector is fierce and it is necessary to work with the issues that affect share trading. A well-functioning share trading is important for creating growth in small and medium-sized companies.
Offer to you as an incubator company
Life for startup companies was not without challenges before the effects of the corona crisis hit, and the situation is now tough for many smaller companies. Now we want to contribute to building Sweden’s next generation of life science companies strong, for future export revenue and innovation power. Startup companies with up to four employees must be members of SwedenBIO for an annual fee of SEK 1,000.
What does the future look like for dual listings in the US? When is the right time? These are questions Adam Kostyal devotes himself to answering in the latest episode of Brännpunkt Life Science.
Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses the magnifying glass on the intersection between innovation, capital and health. In the first part, we meet Adam Kostyal, European head of listing at Nasdaq, who looks at how the stock market year looked for the sector, talks about the impact of the pandemic and shares his predictions for the future.